-
7/6/2010
Swedish Orphan Biovitrum and Dongbao announce Commercial Alliance for the Chinese and European markets
Stockholm, Sweden and Tonghua, China - J...
-
6/23/2010
Change of company name for Biovitrum AB (publ)
Biovitrum AB (publ) will be listed under...
-
4/27/2010
Kiobrina® clinical phase II results trigger milestone payment from Swedish Orphan Biovitrum
Pursuant to the share transfer agreement...
-
4/27/2010
Biovitrum's Interim financial report for the period 1 January to 31 March, 2010
Interim financial report for the period ...
-
4/21/2010
Swedish Orphan Biovitrum has decided to move Kiobrina® into phase III
Stockholm, Sweden – April 21, 2010Swedis...
-
4/15/2010
Swedish Orphan Biovitrum and Pharming sign Rhucin® distribution agreement
Stockholm, Sweden and Leiden, The Nether...
-
4/8/2010
Swedish Orphan Biovitrum launches Willfact® in Germany
Stockholm, Sweden, Les Ulis, France – Ap...
-
4/6/2010
Swedish Orphan Biovitrum makes payment to vendors of Cambridge Biotechnology Limited
Stockholm, Sweden – April 6, 2010Swedish...
-
4/1/2010
Swedish Orphan Biovitrum extends Cyanokit® cooperation with Merck
Stockholm, Sweden – April 1, 2010Swedish...
-
3/23/2010
Swedish Orphan Biovitrum updates European Kepivance® label
Stockholm, Sweden – March 23, 2010 – Swe...
-
3/12/2010
Swedish Orphan Biovitrum has agreed to an additional Kineret® drug campaign with Amgen
Stockholm, Sweden - March 12, 2009 - Swe...
-
2/19/2010
Biogen Idec and Swedish Orphan Biovitrum Update Hemophilia Partnership Agreement
Cambridge, Mass and Stockholm, Sweden – ...
-
1/14/2010
Biovitrum AB (publ) completes the acquisition of Swedish Orphan International Holding AB and resolves on an issue in kind
Biovitrum AB (publ) (”Biovitrum”) has to...